glp-1 + nad Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Week 11 update on my

Your healthcare team, including your primary care physician, endocrinologist, and gynecologist, can collaborate to ensure both your metabolic health goals and reproductive health needs are appropriately addressed

It is the primary anabolic hormone in the body, facilitating glucose uptake into muscle, fat, and liver cells while inhibiting glucose production by the liver

Duttaroy, A., et al

While classical pharmacological tools like metformin and pioglitazone underscore the therapeutic value of MERCS stabilization, these agents primarily function as intracellular sensors and modulators (Angebault et al., 2020

In mid to late 2025, around 12.4% of US adults reported taking a GLP-1 medicine specifically for weight loss, up from 5.8% in February 2024, according to Gallup survey data of more than 15,000 adults

Similar content being viewed by others Introduction Class B G protein-coupled receptors (GPCRs), whose endogenous ligands are peptide hormones, are key mediators of normal human physiology and serve as valuable drug targets for many diseases including diabetes, metabolic syndrome, osteoporosis, migraine, depression, and anxiety 1